Alejandro Martín Muñoz

Head of Bioinformatics

Altum Sequencing S.L.

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Alejandro Martín Muñoz serves as the Head of Bioinformatics at Altum Sequencing S.L. in Spain. His research focuses on the innovative use of circulating tumor DNA (ctDNA) for early detection of minimal residual disease in various hematological malignancies, including breast cancer and lymphoma. Recent publications highlight his work on advanced methodologies for monitoring disease progression and treatment response through non-invasive techniques.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (3)

ROSA MARIA AYALA DIAZ

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

Joaquin Martinez-Lopez

SPAIN

View details

Yolanda Campos-Martín

Profesor Ayudante Doctor

University of Castilla-La Mancha

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alejandro Martín Muñoz

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Exploratory Study to Evaluate the Impact of Interim PET/CT Assessment in First-Line Follicular Lymphoma

Identification of minimal residual disease using the clonesight test for ultrasensitive ctDNA detection to anticipate late relapse in early breast cancer

Potential Utility of Ctdna to Detect False Positive PET/CT in the Evaluation of Lymphoma Response

1176P Potential utility of ctDNA to detect false positive PET/CT in the evaluation of lymphoma response

825P Ultra-sensitive cfDNA analysis for minimally invasive measurable residual disease detection and profiling in multiple myeloma

Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges

Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease.

Adoptively Infused Memory-like Natural Killer Cells Impact Adaptive Immune Responses in Patients with Acute Myeloid Leukemia

Parallel Monitoring of Measurable Residual Disease and Chimerism By NGS in Myelodysplastic Syndrome after Allogenic STEM Cell Transplant

Personalized Monitoring of Circulating Tumor DNA By a Specific Signature of Trackable Mutations after Chimeric Antigen Receptor t-Cell Therapy in Non-Hodgkin B Cell Lymphoma

Collaborators (3)

ROSA MARIA AYALA DIAZ

Joaquin Martinez-Lopez

Yolanda Campos-Martín

Make your next move.